EnglishSGT-151 sgt-151 sgt151 CAS 8378-23-2 SGT151 C12H17NO with competitive price
Product Details
| Place of Origin: | China |
|---|---|
| Brand Name: | |
| Certification: | ISO，CE |
| Model Number: |
Payment Terms
| Min.Order Quantity: | 1 Grams |
|---|---|
| Price: | USD $10 - $100 / Gram |
| Payment Terms: | D/A,Western Union |
Product Description
Product Description
| ProName: | SGT-151 | CAS No: | 8378-23-2 |
| Molecular Formula: | C12H17NO | Appearance: | Powder |
| Application: | Research Purpose | Delivery Time: | 3days |
| Package: | Aluminum foil bag packaging | Port: | China |
| Production Capacity: | 100 Kilogram/Week | Purity: | 99.9% |
| Storage: | A cool,ventilated,dry place | Transportation: | Deliver by EMS;DHL;FEDEX;UPS;TNT |
| Limit Number: | 5Gram | Molecular weight: | 391.478 |
FAQ
1.Q: How is the storage?
A:Keep in dry and cool place.
2.Q: Do I need to pay extra for shipping cost?
A:No, our price includes the shipping cost already; you need not pay for any tax or others.
3.Q: May I order sample to test?
A:Yes, you are welcome to order sample before placing bulk order.We will send the sample directly to your door by courier.
4.Q: What's the delivery time ?
A:Usually , we will ship for you as soon as paid,or 1-2 days after confirm your payment.
CUMYL-PEGACLONE - Wikipedia
CUMYL-PEGACLONE (SGT-151) is a gamma-carboline based synthetic cannabinoid that has been sold as a designer drug. The gamma-carboline core
CUMYL-PEGACLONE - Wikipedia
CUMYL-PEGACLONE (SGT-151) is a gamma-carboline based synthetic cannabinoid that has been sold as a designer drug. The gamma-carboline core
CUMYL-PEGACLONE - Wikipedia
CUMYL-PEGACLONE (SGT-151) is a gamma-carboline based synthetic cannabinoid that has been sold as a designer drug. The gamma-carboline core
Testing for SGT-151 (CUMYL-PEGACLONE) and its
Mar 16, 2019 - To characterize the metabolites of SGT-151, the drug was incubated with a pool of human hepatic microsomes and the cofactors required to
Testing for SGT-151 (CUMYL-PEGACLONE) and its
Mar 16, 2019 - To characterize the metabolites of SGT-151, the drug was incubated with a pool of human hepatic microsomes and the cofactors required to